Trial · NCT04516291
Participant flow48
How many started, completed or left each group, period by period.
21 to 40 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period (24 Weeks) | NOT COMPLETED | Vupanorsen: 80 mg Q2W | 12 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | Vupanorsen: 160 mg Q4W | 8 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | Vupanorsen: 120 mg Q2W | 9 | |
| Treatment Period (24 Weeks) | NOT COMPLETED | Vupanorsen: 160 mg Q2W | 14 | |
| Follow-up Period (12 Weeks) | STARTED | Placebo | 44 | |
| Follow-up Period (12 Weeks) | STARTED | Vupanorsen: 80 mg Q4W | 23 | |
| Follow-up Period (12 Weeks) | STARTED | Vupanorsen: 60 mg Q2W | 24 | |
| Follow-up Period (12 Weeks) | STARTED | Vupanorsen: 120 mg Q4W | 23 | |
| Follow-up Period (12 Weeks) | STARTED | Vupanorsen: 80 mg Q2W | 45 | |
| Follow-up Period (12 Weeks) | STARTED | Vupanorsen: 160 mg Q4W | 45 | |
| Follow-up Period (12 Weeks) | STARTED | Vupanorsen: 120 mg Q2W | 46 | |
| Follow-up Period (12 Weeks) | STARTED | Vupanorsen: 160 mg Q2W | 36 | |
| Follow-up Period (12 Weeks) | COMPLETED | Placebo | 44 | |
| Follow-up Period (12 Weeks) | COMPLETED | Vupanorsen: 80 mg Q4W | 22 | |
| Follow-up Period (12 Weeks) | COMPLETED | Vupanorsen: 60 mg Q2W | 23 | |
| Follow-up Period (12 Weeks) | COMPLETED | Vupanorsen: 120 mg Q4W | 21 | |
| Follow-up Period (12 Weeks) | COMPLETED | Vupanorsen: 80 mg Q2W | 43 | |
| Follow-up Period (12 Weeks) | COMPLETED | Vupanorsen: 160 mg Q4W | 45 | |
| Follow-up Period (12 Weeks) | COMPLETED | Vupanorsen: 120 mg Q2W | 46 | |
| Follow-up Period (12 Weeks) | COMPLETED | Vupanorsen: 160 mg Q2W | 36 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04516291/flow?page=2